Synpromics announces £5.2M British investment in gene therapy tech

By Flora Southey contact

- Last updated on GMT

image: iStock
image: iStock
Scottish synthetic biology firm Synpromics has received £5.2M ($6.6M) to enhance its synthetic promoter design technology used in gene therapy development.

Funding sources include UK-based companies Calculus Capital, the Scottish Investment Bank, the investment branch of Scottish Enterprise, and private shareholders.

The majority of resources will fund the development of Synpromics’ synthetic promoters – DNA sequences that do not exist in nature – via the company’s PromPT design platform.

PromPT is a bioinformatics database for the design, build and screening of synthetic promoters. The promoters allow for precise control of gene function, impacting gene therapy, cell therapy and gene editing.

Synpromics CEO David Venables described the distinct nature of the PromPT platform late last year​ as a “unique capability for the industrialised development of synthetic promoters which doesn’t exist elsewhere.”

Beginning with a team of nine, Synpromics predicts its increase staff size to increase to up to 35 over the next 12 to 18 months.

The deal follows GE Healthcare’s investment​ in the Scottish company earlier this year.

Related news

Show more

Related products

show more

An Intense Focus on Perfusion

An Intense Focus on Perfusion

MilliporeSigma | 09-Oct-2017 | Technical / White Paper

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion...

A Trusted Resin Provider For Over 35 Years

A Trusted Resin Provider For Over 35 Years

Purolite Life Sciences | 18-Sep-2017

Watch our video above to learn more about the history of Purolite Life Sciences.To discuss how we can assist your journey to process excellence, please...

The Next Stage – Eppendorfs new Mastercycler X50

The Next Stage – Eppendorfs new Mastercycler X50

Eppendorf for Bioprocess – Solutions that grow with you | 05-Sep-2017 | Application Note

The Mastercycler X50 is Eppendorf's new PCR cycler with lots of new benefits. Not only can you heat with 10°C/s, you can also optimize two different...

Related suppliers